β-Cell Deletion of Hypoxia-Inducible Factor 1α (HIF-1α) Increases Pancreatic β-Cell Susceptibility to Streptozotocin
2024
Impact of HIF-1α Deletion on Diabetes in Mice
Sample size: 30
publication
Evidence: high
Author Information
Author(s): Josephine Yu, Amit Lalwani, Jenny E. Gunton, Josep Julve
Primary Institution: The University of Sydney
Hypothesis
Mice lacking β-cell-specific HIF-1α will have significantly worsened diabetes after MLDS.
Conclusion
The study demonstrates that β-cell HIF-1α is crucial for preventing diabetes after exposure to streptozotocin.
Supporting Evidence
- 100% of BIN mice developed diabetes after treatment compared to 33% of floxed-control mice.
- BIN mice showed a significant reduction in β-cell mass and increased necrotic areas in islets.
- Adoptive transfer of splenocytes from diabetic BIN mice induced diabetes in all recipient mice.
Takeaway
Researchers found that mice without a specific protein (HIF-1α) in their insulin-producing cells got diabetes much more easily when given a certain drug.
Methodology
The study used a mouse model with β-cell-specific deletion of HIF-1α and treated them with multiple low-dose streptozotocin.
Participant Demographics
The study involved male NOD mice aged 8 weeks.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website